FDA approves Wegovy to lower risk for CVD events in patients with obesity
Mar 08, 2024
Agency’s action could widen access to the drug if more insurance companies decide to cover it
FDA approves drug to help immunocompromised fend off COVID-19
Dec 09, 2021
One dose of Evusheld is administered as two separate, consecutive injections and may be effective for six months.
Increasing dairy intake can cut falls, fractures for seniors
Oct 21, 2021
An intervention to increase calcium and protein intake using dairy foods was beneficial in a study involving older adults who live in long-term care facilities.
Lower frequency of social contact linked to lower total brain volume
Jul 13, 2023
“These results suggest that providing support for people to help them start and maintain their connections to others may be beneficial for preventing brain atrophy and the development of dementia,”...
Incident MI tied to faster declines in cognitive function over time
Jun 05, 2023
Incident myocardial infarction is not associated with a decrease in global cognition, memory or executive function but is associated with faster declines in those measures over time.
FDA gives full approval to Alzheimer’s disease drug Leqembi
Jul 06, 2023
Although Leqembi did help reduce mental decline compared with placebo, the drug has been linked to two deaths from brain bleeds.
Prior SARS-CoV-2 infection ups protection for vaccinated
Nov 15, 2021
Prior infection was linked to a lower risk for breakthrough infection among individuals vaccinated with BNT162b2 (Pfizer-BioNTech) or mRNA-1273 (Moderna).
Company seeks FDA approval for MDMA as treatment for PTSD
Dec 13, 2023
“If approved, MDMA-assisted therapy would be the first psychedelic-assisted therapy, which we hope will drive additional investment into new research in mental health.”
Risk for VTE up for IBD patients infected with SARS-CoV-2
Jun 24, 2021
The odds of VTE increased 8.15-fold according to models adjusting for recent hospitalization and steroid exposure.
FDA approves first drug meant to ease Alzheimer’s disease-llnked agitation
May 11, 2023
Patients who received 2 or 3 mg of Rexulti had significant improvements in agitation scores compared with patients taking a placebo.